CUV 0.66% $15.10 clinuvel pharmaceuticals limited

Ann: Appendix 4C - quarterly, page-7

  1. 211 Posts.
    lightbulb Created with Sketch. 15
    "We look forward to the time the same treatment access can be provided to American EPP patients who have no current alternatives" - If that happens with FDA approval in October, where the SP will be?
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.